Drugs / PAZ320
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04569214 | Sep 2012 → Feb 2013 | type 2 diabetes mellitus | Boston Therapeutics | Withdrawn | No outcome recorded |
| Phase 2 | NCT02060916 | Mar → Aug 2011 | diabetes mellitus, noninsulin-dependent, 2 | Boston Therapeutics | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PAZ320 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04569214 ↗ |